Trial site
Hyderabad
- 10running trials
- 13closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy3 trials
- Multiple sclerosis3 trials
- Chronic spontaneous urticaria2 trials
- Coronary artery disease2 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Sickle cell disease2 trials
- Stroke2 trials
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Familial hypercholesterolaemia1 trial
- Lupus (SLE)1 trial
- and 3 more
- Phase
- Phase 316 trials
- Phase 44 trials
- Phase 22 trials
- Status
- Completed11 trials
- Active, not recruiting9 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals23 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Completed
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Terminated
Completed
Completed
Completed
Completed
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026